Cargando…
Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis
Autores principales: | Moin, Abu Saleh Md, Al-Qaissi, Ahmed, Sathyapalan, Thozhukat, Atkin, Stephen L., Butler, Alexandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753193/ https://www.ncbi.nlm.nih.gov/pubmed/33364597 http://dx.doi.org/10.1016/j.metop.2020.100074 |
Ejemplares similares
-
Letter to the Editor: Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)